Mandate

Vinge advises Smart Eye Aktiebolag (publ) on its first SEK 300 million bond issue

December 12, 2025 M&A

Vinge has advised Smart Eye Aktiebolag (publ) (“Smart Eye”) on the company’s first issue of senior unsecured bonds in an aggregate principal amount of SEK 300 million, under a framework of up to SEK 600 million. Skandinaviska Enskilda Banken AB (publ) acted as sole bookrunner in connection with the bond issue.

Smart Eye is a Swedish technology company within Human Insight AI, a technology that understands, supports, and predicts human behavior in complex environments. Smart Eye’s technology is integrated into next-generation vehicles and delivers insights across, among others, the automotive, aviation, and space industries.

The bonds have a floating interest of 3M STIBOR + 700 basis points and have a tenor of three-years. In accordance with the terms and conditions of the bonds, the proceeds from the issuance of the bonds will be used to (i) refinance existing indebtedness and (ii) finance general corporate purposes (including transaction costs and acquisitions). Smart Eye intends to apply for the bonds to be admitted to trading on Nasdaq Stockholm’s corporate bond list within 12 months from the issue date and on Nasdaq Transfer Market within 30 days.

Vinge’s team consisted of Anders Strid, Lionardo Ojeda, Edin Agic and Sofia Haggren.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026